Stock CZO CEAPRO INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Ceapro Inc.

Equities

CZO

CA1499071076

Delayed Toronto S.E.
Other stock markets
 18:07:46 31/05/2024 BST 		5-day change 1st Jan Change
0.225 CAD -11.76% Intraday chart for Ceapro Inc. -.--% +18.42%
06-03 Aeterna and Ceapro Brief: Cos Complete Merger Transaction; New Name Expected to be Announced in Coming Weeks and Details of AGM Expected to be Announced Shortly MT
06-03 Aeterna Zentaris Inc. completed the acquisition of Ceapro Inc. in a merger of equals transaction. CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Aeterna and Ceapro Brief: Cos Complete Merger Transaction; New Name Expected to be Announced in Coming Weeks and Details of AGM Expected to be Announced Shortly
MT
Aeterna Zentaris and Ceapro Complete Merger Transaction
GL
Aeterna Zentaris and Ceapro Complete Merger Transaction
AQ
Canadian Investment Regulatory Organization Trading Halt - CZO
AQ
Aeterna Zentaris Inc. completed the acquisition of Ceapro Inc. in a merger of equals transaction.
CI
Ceapro's Q1 Net Loss Swells YoY, But Talks Up Benefits of Planned Aeterna Merger
MT
Ceapro Inc. Reports Financial Results for First Quarter 2024 and Provides Corporate Update
GL
Ceapro Inc. Reports Financial Results for First Quarter 2024 and Provides Corporate Update
AQ
Ceapro Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Aeterna Zentaris Finalizes Some Details for Ceapro Merger
MT
Aeterna and Ceapro Brief: Aeterna Zentaris Announcing Details Regarding Transaction with Ceapro
MT
Ceapro Inc. Reports 2023 Financial Results and Operational Highlights
GL
Ceapro Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Ceapro Inc. Reports 2023 Financial Results and Operational Highlights
AQ
Ceapro Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Ceapro Brief: Parties anticipate completing Transaction in Q2 2024, subject to obtaining all required approvals and satisfying all required conditions
MT
Ceapro Brief: Says Received Final Court Approval for Merger with Aeterna Zentaris
MT
Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris
GL
Aeterna Zentaris Reports Q4 Net Loss of US$5.6 Million, Provides DETECT Trial Update
MT
Aeterna Zentaris Brief: Announcing Completion of Enrollment in Ongoing Pivotal DETECT-Trial for Diagnosis of Childhood-Onset Growth Hormone Deficiency
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CZO Stock
  4. News Ceapro Inc.